N-[3-[(1R)-1-[(2-amino-5-chloro-3-pyridinyl)oxy]ethyl]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide
C26H30ClN5O2 — CID 139506738
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[(1R)-1-[(2-amino-5-chloro-3-pyridinyl)oxy]ethyl]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide
N-[3-[(1R)-1-[(2-amino-5-chloro-3-pyridinyl)oxy]ethyl]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide (PubChem CID 139506738) has the molecular formula C26H30ClN5O2 and a molecular weight of 480.01 g/mol. Its IUPAC name is N-[3-[(1R)-1-[(2-amino-5-chloro-3-pyridinyl)oxy]ethyl]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide.
Molecular Properties
| Compound Name | N-[3-[(1R)-1-[(2-amino-5-chloro-3-pyridinyl)oxy]ethyl]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide |
|---|---|
| PubChem CID | 139506738 |
| Molecular Formula | C26H30ClN5O2 |
| Molecular Weight | 480.01 g/mol |
| Exact Mass | 479.21 |
| IUPAC Name | N-[3-[(1R)-1-[(2-amino-5-chloro-3-pyridinyl)oxy]ethyl]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide |
| SMILES | C[C@@H](Oc1cc(Cl)cnc1N)c1cccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)c1 |
| InChI | InChI=1S/C26H30ClN5O2/c1-18(34-24-15-22(27)16-29-25(24)28)21-4-3-5-23(14-21)30-26(33)20-8-6-19(7-9-20)17-32-12-10-31(2)11-13-32/h3-9,14-16,18H,10-13,17H2,1-2H3,(H2,28,29)(H,30,33)/t18-/m1/s1 |
| InChIKey | VLUPEFKRUYPWTO-GOSISDBHSA-N |
| XLogP | 4.46 |
| TPSA | 83.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.01 |
| LogP ≤ 5 | 4.46 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139506738 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.